跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONDANSETRON INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ONDANSETRON INJECTION USP
Authorized
STANDARD
ONDANSETRON INJECTION USP
Accord Healthcare Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e70e5ccc22a02349
Company
Accord Healthcare Inc
Type
Standard
Approval Details
Approval Id
e70e5ccc22a02349
Drug Approval Canada Name
ONDANSETRON INJECTION USP
Product Name
ONDANSETRON INJECTION USP
Status
Cancelled Pre Market
Status Date
2025-06-09
Din
02367297
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
56:22.00
Atc Original
A04AA01 ONDANSETRON
Atc Name
a 04 aa 01
Aig Number
0131120004
Company Name
Accord Healthcare Inc
Company Address
3535 Boulevard St-Charles, Suite 704, Kirkland, Quebec, Canada, H9H 5B9
Company Detail Path
/organization/accord-healthcare-inc
Company Information
Pharmaceutical Company Name
Accord Healthcare Inc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
704-3535 boul Saint-Charles
Active Ingredients
ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE)
2 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e70e5ccc22a02349
Type
Standard
Back to Health Canada Approvals